Year |
Citation |
Score |
2014 |
Ashlock BM, Ma Q, Issac B, Mesri EA. Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication. Plos One. 9: e87324. PMID 24489895 DOI: 10.1371/Journal.Pone.0087324 |
0.688 |
|
2014 |
Bayraktar UD, Diaz LA, Ashlock B, Toomey N, Cabral L, Bayraktar S, Pereira D, Dittmer DP, Ramos JC. Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas. Leukemia & Lymphoma. 55: 786-94. PMID 23837493 DOI: 10.3109/10428194.2013.818142 |
0.559 |
|
2013 |
Mesri EA, Cavallin LE, Ashlock BM, Leung HJ, Ma Q, Goldschmidt-Clermont PJ. Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis. Immunologic Research. 57: 159-65. PMID 24203444 DOI: 10.1007/S12026-013-8458-Z |
0.597 |
|
2013 |
Bhatt S, Ashlock BM, Natkunam Y, Sujoy V, Chapman JR, Ramos JC, Mesri EA, Lossos IS. CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma. Blood. 122: 1233-42. PMID 23838350 DOI: 10.1182/Blood-2013-01-481713 |
0.706 |
|
2013 |
Bhatt S, Ashlock BM, Toomey NL, Diaz LA, Mesri EA, Lossos IS, Ramos JC. Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma. The Journal of Clinical Investigation. 123: 2616-28. PMID 23635777 DOI: 10.1172/Jci64503 |
0.693 |
|
2011 |
Daftarian P, Chowdhury R, Ames P, Wei C, King AD, de Rivero Vaccari JP, Dillon L, Price J, Leung H, Ashlock B, Mesri E, Perez V, Züchner S, Reiser J, Lemmon V, et al. In vivo electroporation and non-protein based screening assays to identify antibodies against native protein conformations. Hybridoma (2005). 30: 409-18. PMID 22008067 DOI: 10.1089/Hyb.2010.0120 |
0.6 |
|
2011 |
Bhatt S, Ashlock B, Natkunam Y, Ramos JC, Mesri E, Lossos IS. Preclinical Activity of Brentuximab Vedotin (SGN-35) in Primary Effusion Lymphoma (PEL), Blood. 118: 3728-3728. DOI: 10.1182/Blood.V118.21.3728.3728 |
0.689 |
|
2011 |
Bhatt S, Ashlock B, Toomey N, Mesri E, Ramos JC, Lossos IS. Synergistic Preclinical Activity of Bortezomib with Suberoylanilide Hydroxamic Acid (SAHA) in Primary Effusion Lymphoma (PEL) Blood. 118: 1650-1650. DOI: 10.1182/Blood.V118.21.1650.1650 |
0.711 |
|
2005 |
Schmidt B, Ashlock BM, Foster H, Fujimura SH, Levy JA. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology. 343: 256-66. PMID 16278001 DOI: 10.1016/J.Virol.2005.09.059 |
0.315 |
|
2004 |
Schmidt B, Ashlock B, Neipel F, Levy JA. Potential screening assay for undetectable viruses on the basis of their capacity to induce alpha interferon production. Journal of Clinical Microbiology. 42: 4300-2. PMID 15365027 DOI: 10.1128/Jcm.42.9.4300-4302.2004 |
0.344 |
|
Show low-probability matches. |